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Abstract
Cardiac progenitor formation is one of the earliest committed steps of human car-
diogenesis and requires the cooperation of multiple gene sets governed by develop-
mental signaling cascades. To determine the key regulators for cardiac progenitor
formation, we have developed a two-stage genome-wide CRISPR-knockout screen.
We mimicked the progenitor formation process by differentiating human pluripotent
stem cells (hPSCs) into cardiomyocytes, monitored by two distinct stage markers of
early cardiac mesodermal formation and commitment to a multipotent heart progeni-
tor cell fate: MESP1 and ISL1, respectively. From the screen output, we compiled a
list of 15 candidate genes. After validating seven of them, we identified ZIC2 as an
essential gene for cardiac progenitor formation. ZIC2 is known as a master regulator
of neurogenesis. hPSCs with ZIC2 mutated still express pluripotency markers. How-
ever, their ability to differentiate into cardiomyocytes was greatly attenuated. RNA-
Seq profiling of the ZIC2-mutant cells revealed that the mutants switched their cell
fate alternatively to the noncardiac cell lineage. Further, single cell RNA-seq analysis
showed the ZIC2 mutants affected the apelin receptor-related signaling pathway dur-
ing mesoderm formation. Our results provide a new link between ZIC2 and human
cardiogenesis and document the potential power of a genome-wide unbiased
CRISPR-knockout screen to identify the key steps in human mesoderm precursor
cell- and heart progenitor cell-fate determination during in vitro hPSC cardiogenesis.
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1 | INTRODUCTION
Cardiac progenitors emerge from the mesoderm precursor cells right
after gastrulation. Other lineages, such bone and muscle, are also gen-
erated from these mesoderm precursor cells. The regulation of the
cell-fate commitment of these precursor cells holds the key to under-
stand the development and differentiation to the specific cell lineage.
Cardiac progenitor formation is one of the earliest committed steps in
human cardiogenesis and requires the cooperation of multiple gene
sets governed by developmental signaling cascades. The cell-fate deci-
sions are controlled by both the internal genetic factors and the exter-
nal signaling cues from the environment. The in vitro model systems
of human pluripotent stem cell (hPSC) differentiation enable us to
control the external signaling cues, leaving the genetic factor as the
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main component in cell-fate decision. Thus, a genetic screen approach
on such a system may perhaps reveal the important genes that control
the cell-fate decisions of both the mesodermal precursor cells and the
cardiac progenitor cells during cardiogenesis.
CRISPR-knockout screen technology has been developed shortly
after the establishment of CRISPR-Cas9 genome editing system
in mammalian cells.1,2 Due to its feasibility and simplicity, the CRISPR-
Cas9 system can be easily scaled up and integrated with an array
synthesis system and/or mass parallel sequencing. CRISPR screen is a
forward genetic approach, usually performed in pool screen manners.
It is a versatile tool to discover genes associated with a specific phe-
notype in an unbiased fashion. CRISPR screens have been used in
identifying genes for fitness of the cells,3 signaling transduction,4-7
survival, tumor metastasis,8 drug resistance,9 muscle formation,10 and
cellular metabolism.11,12 Herein, we report a CRISPR-knockout screen
to investigate the cell-fate decision and lineage specification in
cardiogenesis. By combining a highly efficient cardiac differentiation
protocol with the CRISPR screen, we have developed a two-stage
genome-wide CRISPR-knockout screen system for identifying the key
regulators in cardiac progenitor formation and commitment.
From the screen outputs, we compiled a list of 15 candidate genes.
After validating seven genes of them, we identified ZIC2 as a new
essential gene for regulating cardiac progenitor formation. Importantly,
our study provides a new link between ZIC2 and human cardiogenesis
and documents the potential power of the genome-wide unbiased
CRISPR screen to identify the key steps in human mesoderm precursor
cell- and heart progenitor cell-fate determination during human car-
diogenesis, recapitulated in in vitro hPSC model systems.
2 | MATERIALS AND METHODS
2.1 | hESC culture and differentiation
Human pluripotent stem cells (ES03, NIH code: HES3) were
maintained on Vitronectin (Thermo Fisher Scientific, Paisley, UK)
coated plates in Essential 8 (Thermo Fisher Scientific) medium and
passaged with Versene (Thermo Fisher Scientific). Both small molecule
and growth factors based cardiac differentiation of hESCs were per-
formed according to previously published growth factor based
methods.13-16 Please see the supplemental method for details.
2.2 | Cell line generation
2.2.1 | Generation of Cas9 hPSC line
The lentiviral plasmid Cas9-NLS-FLAG-2A-Bsd was cotransfected into
HEK293T cells with packaging plasmids psPAX2 and pMD2.G (Addgene,
12260 and 12259). HEK293T cells were cultured in high-glucose DEME
+10% FBS. Virus-containing media were collected at 48 and 72 hours
after transfection and used for hPSC infection. Transduced cells were
selected based on resistance to 1 μg/mL puromycin.
2.2.2 | Generation of ZIC2 mutated hPSC lines
Three plasmids, pPB-CRISPR-ZIC2-g1/2 and pCyL43, were used for
genome editing in hPSCs. Two million hPSCs, 1 μg pCyL43 and 4 μg
pPB-CRISPR-ZIC2-g1/2 DNA were mixed in 100 μL nucleofection solu-
tion and then nucleofected with program B-16 using a Nucleofector 2b
device (Lonza, Zurich, Switzerland). After 2 weeks of 0.5 μg/mL puromy-
cin selection, cells were singularized and sparsely seeded to generate sin-
gle cell derived clones.
Other mutants, PLEKH02, CTSV, TTC39B, SEMA3B, MAGIX were
generated in the same way. SMAD4 clones were reused from previous
study and were generated in the same way.
2.3 | Generation of hPSC mutant libraries
The virus packaging and transfection was carried out in the virus lab.
The library and two other lentivirus packaging plasmid psPAX2, and
pMD2.G were transfected into 293TN cells with FuGENE HD
(Promega, Madison, Wisconsin). The supernatants were collected at
48 and 72 hours after transfection and used to infection the Cas9
expressing ES03 cells. A 5 μg/mL Blasticidin selection was applied for
2 weeks. And the libraries were cultured for another 2 weeks before
experiments.
2.4 | Mutation sequencing
Genomic DNA was extracted from putative ZIC2 mutated hPSCs using
Quick-gRNA MiniPrep kit (Zymo Research, Irvine, California, D3007).
The targeted genome region was amplified primer pairs, forward:
GGCGCAGAACGGCTTCGTTG and reverse: TGCTCAGTTGCTCGG
GGTCG. The amplified polymerase chain reaction (PCR) fragment was
inserted into pCR4TOPO vector via the TOPO-TA method (Thermo
Fisher Scientific). Plasmids from individual Escherichia coli clones were
Sanger Sequencing using a T7 primer.
Significance statement
In order to unbiasedly uncover the regulators that control the
formation of human cardiac progenitor, a genome-wide
CRISPR-knockout screen based on cardiac differentiation
from human embryonic stem cells (hESCs) was developed.
From the screen output, ZIC2 as an essential gene for cardiac
progenitor formation was identified. The results of the study
provide a new link between ZIC2 and human cardiogenesis
and document the potential power of genome-wide unbiased
CRISPR-knockout screens to identify key steps in heart pro-
genitor fate determination during human cardiogenesis with
hESC model systems.
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2.5 | Genomic sgRNA library preparation
Genomic DNA was extracted with Zymo-DNA Miniprep Kit (D3024)
or Zymo FFPE DNA MiniPrep Kit (D3065) according to the manuals.
Genomic DNA from the hESC libraries were extracted with Zymo-
DNA Miniprep Kit. And the sorted cell population were fixed with 4%
formaldehyde solution, so proteinase K digestion step were included,
and Zymo FFPE DNA MiniPrep Kit were used to extract the genomic
DNA in these cells.
A two-step PCR were used to prepare the sequencing library. In the
first PCR reaction, the sgRNA containing region were amplify from the
genomic DAN with lib-seq primers: lib-seq-fwr: ACACTCTTTCCC
TACACGACGCTCTTCCGATCTgaggaTTGTGGAAAGGACGAAACACCG
and lib-seq-rvs: AGACGTGTGCTCTTCCGATCTtctactattctttcccctgcactgt.
In the second PCR reaction, sequencing adaptor and multiplex
index were added by illumina's Nextra adaptor primers. The final PCR
product were size-selected with E-Gel system and purified. The final
libraries were qualified with bio-analyzer. And the finished libraries
were send to SciLifeLab for sequencing.
2.6 | CRISPR screen data processing
Fastq files were fed into a perl script to extract the sgRNAs. The
extracted sgRNA sequences were aligned to the human genome
sequence with bowtie. Good alignments were annotated with a GTF file
using bedtools. In the final step, a table was generated showing the
sgRNA sequencing, genome coordinates, targeted gene information, and
the count numbers. The count table is fed into edgeR to compute the
“differential” genes between the different groups as the candidate genes.
2.7 | Antibodies
POU5F1 (sc-5279, Santa Cruz, Heidelberg, Germany); NANOG
(4903S, Cell Signaling, Leiden, Netherlands); SOX2 (3579, Cell Signal-
ing); PAX6 (DSHB, Iowa, Iowa); TBXT (AF2085, R&D system, Minne-
apolis, Minnesota); MESP1 (ab77013, Abcam, Cambridge, UK); ISL1
(39.4D5, DSHB); NKX2-5 (sc-14 033, Santa Cruz); TNNT2 (MS-
295-P1, ThermoFisher Scientific); V5 (R960-25, ThermoFisher Scien-
tific); ZIC2 (ab150404, Abcam).
2.8 | Flow cytometry
Cells were dissociated into single cells with Accutase (STEMCELL Tech-
nologies, Cambridge, UK) for 10 minutes and subsequently fixed with
1% paraformaldehyde for 20 minutes at room temperature and stained
with primary and secondary antibodies in PBS with 0.2% Triton X-100
and 0.5% BSA. Data were collected on a FACSCaliber or FASCanto flow
cytometer (Becton Dickinson, Franklin Lakes, New Jersey) and analyzed
using FlowJo. Fluorescence-activated cell sorting (FACS) gating was
based on the corresponding isotype or secondary only antibody control.
2.9 | Immunostaining
Cells were fixed with 4% paraformaldehyde for 15 minutes at room tem-
perature and stained with primary and secondary antibodies in PBS plus
0.4% Triton X-100 and 5% nonfat dry milk. Nuclei were stained with
DAPI. A ZEISS LSM 700 confocal microscope was used for imaging.
2.10 | RNA sequencing
Total RNA was isolated with Direct-Zol RNA Kits (Zymo Research).
RNA quality was checked with BioAnalyzer 2100 (Agilent, Santa Clara,
California). Library preparation type was Illumina TruSeq Stranded
mRNA, Poly-A selection. Samples were sequenced on HiSeq2500
with a 2 × 126 setup using HiSeq SBS Kit v4 chemistry. Basic data
processing was performed in the SciLifeLab facility. Briefly, the
FASTQ files were mapped to Human Genome, GRCh37 with STAR
aligner.17 The outputted binary version of a Sequence Alignment/Map
(BAM) files were used for further analysis described later.
2.11 | RNA-Seq analysis
The expression count table was produced by feeding FeatureCounts18
with the BAM files produced in the data process step and annotation
file gencode.v27lift37 from GENCODE. Differential gene expression
analysis was performed with R package edgeR.19 Gene expression
pattern analysis was performed with k-mean function in R. Analysis
and graphs were produce with custom scripts available by request.
2.12 | Single cell RNA-seq
The cryo-preseved day 3 samples were thawed at 37C and stained with
Sytox Blue (Thermo Fisher Scientific). The Sytox blue negative popula-
tion contained the live cells and were FACS sorted into 384-well plate,
which contains the lysis buffer for single cell RNA-seq library preparation
provided by the single cell RNA-seq facility in Integrated Cardio Meta-
bolic Centre (ICMC), Department of Medicine, Huddinge, Karolinska
Institutet. Strict gate had been applied to minimize the chance of more
than one cell in each well. Three plates were sequenced, including one
vial of wild type ES03, ZIC2 mutant clone 1 and clone 2. Single cell RNA
libraries were prepared using the Smart-seq220 protocol and sequenced
with HiSeq2000 using 50 bp single read mode. The outputted FASTQ
files were mapped to Human Genome, GRCh37 with HISAT2 aligner.21
The outputted BAM files were used for further analysis described later.
2.13 | Single cell RNA-seq analysis
The expression count table was produced by feeding FeatureCounts18
with the BAM files produced in the data process step and annotation
file gencode.v27lift37 from GENCODE. The count table and
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annotation information are integrated into SingleCellExperiment,22 an
R object for single cell RNA-seq analysis. Cells with less than 7e3
genes expressed or total read count below 1.2e5 is filtered out.
And genes that expressed in less than five cells are also excluded from
the analysis. The number of cells passed final quality control (QC) is
1043, and the number of genes include in the analysis is 26 033. After
the QC, we used R-package: scran,23 to calculate the size factor for each
cell according to the internal housekeeping genes and normalized the
read counts for further analysis. T-SNE map is generated using t-SNE
algorithm integrated in the SingleCellExperiment package. Cell clustering
and marker gene identification are analyzed by sc3,24 another R package
for single cell RNA-seq analysis. The gene expression plot on the t-SNE
map is plotted with customized R-script with ggplot2 package.
2.14 | Animal experiments
The animals’ care was in accordance with the institutional guidelines
of the Karolinska Institutet, and all animal experiments were approved
by the local ethics committee (Stockholm, Sweden) in accordance with
the Animal Protection Law, the Animal Protection Regulation, and the
Regulation of the Swedish National Board for Laboratory Animals.
Please refer the supplemental methods for the generation of mutant
embryos with microinjection of zygotes.
3 | RESULTS
3.1 | Generation of hESC mutation libraries
Generation of a high-quality cell library is needed as the foundation of a
genome-wide screen. We first engineered human embryonic stem cells
(hESCs) constitutively expressing Cas9 using an ES03 cell line and a plas-
mid pLentiCas9Bsd.25 After three passages of selection, as shown in
Figure S1A, the cells expressed Cas9 uniformly, indicated by the expres-
sion of flag tags that attach at the C-terminal of Cas9. We further tested
the differentiation efficiency of this cell line, and highly efficient differenti-
ation could be eventually achieved (Figure S1B), making it suitable for the
screen. Next, we transfected the cells with the sgRNA lentiviral library
(see Methods). The transfection was carried out with an optimized low
viral titer to avoid too many copies of insertions in one single cell. To
increase the library coverage, three independent transfections were per-
formed, and thus, three hESC libraries were generated (Figure S2B). These
hESC libraries were separately maintained over 4 weeks to achieve the
maximum on-target effect but inversely only the limited off-target effect.
Immediate after the transfection, some gene mutations may cause
the cell death or slow growth, resulting in a dropout from the screen
of CRISPR-knockout genes that potentially affect cardiac differentia-
tion. After 4 weeks culture when the transduced hESC libraries should
be stably settled down, we sequenced the genomic DNAs of the three
libraries, respectively, and checked the sgRNAs they were carrying. In
total, 47 million reads were obtained. We filtered out sgRNAs with
total reads below 500, and found that the transduced sgRNAs finally
targeted around 6000 genes. Eighty percent of those sgRNAs were
overlapped among the libraries, showing the reproducibility of gener-
ating the hESC mutant libraries (Figure S2C).
Since these libraries can self-renew and be differentiated into a
wide variety of specific cell types, their applications are considered to
be limitless. As one example, we performed a small screen to uncover
genes responsible for the cell death induced by dissociation of hESCs.
The cells carrying mutations in these genes might have a growth advan-
tage over the other cell types. Identifying these genes likely helped to
better interpret the screen outcome. The survival rate of hESCs after
cell dissociation is usually around 1%, without using
p160-Rhoassociated coiled-coil kinase (ROCK) inhibitors. Even with a
ROCK inhibitor, the survival rate increases but is only 27%.26 If cells
from the library carrying gene mutation that can disrupt the ROCK sig-
naling pathway, they were likely to be naturally resistant to this sort of
mechanical and chemical stress to cells and to have growth advantages
rather than normal or other mutant cells. To prove this hypothesis, we
pooled a small library from the three main libraries and passaged them
without using a ROCK inhibitor. After two passages, only a few colonies
survived. They could not only proliferate continuously, but also survive
after the freeze-and-thawed stress without addition of a ROCK inhibi-
tor. We extracted the genomic DNAs from these cells and amplified the
sgRNAs integrated in their genome. With a simple TA-cloning method,
we could separate the sgRNAs into individual plasmids, and 20 of them
were sequenced. We found a list of genes whose mutations were
responsible for the growth advantage of these cells. They involved
PMAIP1 (22%), RYBP (17% + 5%), MYH9 (17%), PCGF1 (5%), ZNF418
(5%), STOML1 (5%), GLYATL2 (5%), and B3GALT6 (5%) (Figure S2D).
Taken together, we successfully created the three hESC mutant libraries
for the CRISPR screen and managed to test the screen principle by iden-
tifying the genes associated with the potential cell growth advantage.
3.2 | Screen for essential genes for the formation
of cardiac mesoderm and progenitors
We pooled the three hESC mutant libraries together to create one
large genome-wide mutated library, covering more than 6000 genes.
We differentiated the library and carried out the screening in the
cardiac mesoderm and progenitor stages.
To screen the essential genes for the formation of cardiac mesoder-
mal precursor cells, we used MESP1 as a cardiac mesoderm marker. The
cardiac mesoderm stage was corresponding to day 3 in cardiac differen-
tiation in vitro, when more than 95% of the wild type hESC-derived
cells were MESP1 positive. We used a MESP1 antibody to separate the
mutant hESC-derived cells on day 3 into MESP1+ and MESP1−
populations via FACS. Theoretically, the cells with mutation of an essen-
tial gene for cardiac mesoderm formation failed to express MESP1 and
were enriched in the MESP1− population. Therefore, by comparing inte-
grated sgRNAs between MESP1+ and MESP1− populations sorted on
day 3, the sgRNA-targeted essential genes for cardiac mesoderm forma-
tion could be identified as genes enriched in the MESP1− population
but not found in the MESP1+ population (Figure 1A).
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Next, to screen the essential genes for the formation of cardiac
progenitors, we used ISL1 as a cardiac progenitor marker. At the pro-
genitor stage such as day 6 in cardiac differentiation, more than 90% of
wild type hESC-derived cells expressed ISL1. The mutant hESC-derived
cells were separated into ISL1+ and ISL1− populations. Similar to the
screening at cardiac mesoderm stage, cells with mutation of an essential
gene for cardiac progenitor induction failed to express ISL1 and were
enriched in the ISL1− population on day 6 (Figure 1A).
To minimize the enrichment of negative population due to a low
efficiency of cardiac differentiation, we differentiated the libraries multi-
ple times, eight for cardiac mesoderm formation and 10 for cardiac pro-
genitor induction, and the three attempts with the most efficient cardiac
differentiation were chosen for further analyses, in which the highest
percentages of MESP1 or ISL1 positive cells were obtained (Figure 1B).
In total, six populations were collected, and genomic DNAs of those
cells were extracted. The sgRNA regions integrated into the genome
were amplified with a nest-PCR method. Adapters for massive parallel
sequencing were added during the second PCR step (see Methods).
HiSeq2500 (Illumina, San Diego, California) was used to sequence these
sgRNA amplicons, which were extracted and aligned to the human
genome. Then, sgRNA count tables were generated and fed into the
edgeR program to compare and detect the differential expression genes
between the negative and positive populations for Mesp1 and Isl1.
3.3 | Validation of candidate genes essential for
the formation of cardiac mesoderm and progenitors
As shown in Figure 1C, the well-known cardiac genes, such as TBXT,
MESP1, ISL1, and NKX2-5, did not show on top of the list, suggesting
these genes might not be as essential for the formation of cardiac
mesoderm or progenitors as previously thought. Among the top candi-
dates of essential genes for cardiac mesoderm or cardiac progenitor
formation (Figure 1C), SMAD4 is the most well-known gene, a key
component in TGFβ superfamily signaling pathways.27 Its effect on
cardiac differentiation was reported and thus predictable. Besides
SMAD4, we compiled a list of 15 candidate genes. From the Mesp1+
cardiac mesoderm screening, MAD2L1, PPP3CC, ZIC2, PODXL, NAPA,
GPR4, and TTC39B were identified as the top candidates. From the
ISL1+ cardiac progenitor screening, SEMA3B, MAGIX, TRUB2, SMAD4,
FBXL19, CTSV, PLEKHO2, NOX3, and DFFA were identified as the top
candidates (Figure 1C).
F IGURE 1 Cardiac mesoderm and
progenitor stage screening. A, Schematic
shows the screening strategy.
B, Examples of flow cytometry plots show
the sorting of MESP1 or ISL1 positive and
negative populations. In total, eight
batches of mesoderm differentiation
(collected on day 3), and 10 batches of
progenitor differentiation (collected on
day 6) were performed. The best three
differentiation attempts were chosen for
further sequencing analyses. C, Heat
maps show the genes with sgRNAs
enriched in marker negative and positive
populations
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Next, we sought to validate the effects of these candidate genes in
the in vitro cardiogenesis using the PiggyBac CRISPR system.27 We
worked on two or three genes at a time and identified two genes after
testing seven of the most promising genes, namely SMAD4, PLEKHO2,
CTSV, TTC39B, ZIC2, SEMA3B, and MAGIX (Figure 2A). Among these
candidate genes, SMAD4 was the most essential gene for car-
diomyocyte differentiation, as our previous study also showed that
SMAD4 was indispensable for the formation of cardiac mesodermal pre-
cursor cells.27 Thus, the identification of SMAD4 validated the results of
the screening as a positive control. In addition, we identified ZIC2 as a
new essential gene for cardiomyocyte differentiation of hESCs in vitro.
Some of the clones from CTSV, SEMA3B, and MAGIX mutants also
showed the reduction of the cardiac differentiation efficiency
(Figure 2A). However, because the effects of these genes were not as
prominent, we decided to focus on ZIC2, the mutants of which
exhibited the reduction of the cardiac differentiation efficiency to less
than 8% (Figure 2A). The mutation sequence of the ZIC2 mutants are
illustrated in Figure 2B. Both alleles of clone 1 and 2 had deletions in
the targeted site, while one allele from clone 5 also had deletion and
was identical to one allele of the clone 2 alleles. Flow cytometry analy-
sis showed that less than 6% of the ZIC2 mutant-derived cells on day
14 in cardiac differentiation expressed TNNT2, while more than 80% of
the wild type hESC-derived cells were positive for TNNT2 (Figure 2C).
To further demonstrate the requirement of ZIC2 in in vitro cardiac
differentiation of hESCs is independent of the differentiation protocol
types, we used an Activin A/BMP4 protocol adopted from previous stud-
ies13-16 to differentiate the ZIC2-mutated hESCs into cardiomyocytes.
After 14 days of differentiation, the wild type hESCs yielded 60%
TNNT2+ cardiomyocytes, while the mutants produced no detectable
cardiomyocytes (Figure 2C,D).
Taken together, we validated seven candidate genes and identi-
fied SMAD4, as a positive control for the screening, and ZIC2, as a
new essential gene, for human cardiac mesoderm and progenitor
formation.
F IGURE 2 Identification of
ZIC2 as an essential gene among
the candidates. A, Statistical
summary of validated candidate
genes (n = 4, from two batches
differentiations of each
candidates). B, Mutated sequences
in ZIC2 loci. Clone 1 has two
patterns: 64 and 17 deletions.
Clone 2 has two patterns: 64 and
65 deletions. Clone 5 has one
pattern: 64 deletions. C, Flow
cytometry analysis show ZIC2
mutated hPSCs reduced the
cardiomyocyte differentiation
efficiency using Activin A/BMP4
method. D, Bar graph shows the
statistical summary of the
cardiomyocyte differentiation
efficiency using Activin A/BMP4
protocol (n = 3, wild type was
from 1 batch of differentiation and
mutants were from 2 batches of
differentiations)
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3.4 | ZIC2 mutants reduce cardiac lineage
commitment from early mesodermal precursors
Next, we investigated the mechanistic aspects underlying the failure
of cardiomyocyte differentiation in the ZIC2 mutants. We first exam-
ined the appearances of ZIC2 mutants in each of the hESC differentia-
tion stages. Although bright field images showed the colonies from
ZIC2 mutants were not as compact as the wild type (Figure S3A),
immunostaining images showed POU5F1 and NANOG were
expressed in ZIC2 mutants as well as in the wild type (Figure S3B).
This suggested that the ZIC2 mutants hold their pluripotency state,
according to these markers’ expression.
When the cardiac differentiation was initiated, the wild type hESCs
would go through similar stages as embryonic development: on day
1, after 24 hours of stimulation by a GSK3β inhibitor, hESCs differenti-
ated into TBXT (also known as Brachyury T)-positive cells, resembling
the in vivo cells locating at the primitive streak; on day 3, the cells
transformed into MESP1-positive cells, resembling the in vivo cardiac
mesodermal precursor cells migrating through the primitive streak
toward the anterior pole; and on day 6, ISL1-positive cardiac progeni-
tors emerged from the cultured cells, indicating the formation of heart
field progenitors. On the contrary, the ZIC2 mutants failed to express
MESP1 at protein level on day 3 (Figure 3A), suggesting the failure of
cardiac mesoderm formation. Interestingly, on day 6, the ZIC2 mutant
could also express ISL1, a classical second heart field marker28-32
(Figure 3B). On day 8, the progenitors from the wild type cells differen-
tiated into cardiomyocytes expressing NKX2-5 and TNNT2 (Figure 3C).
However, only few of the ZIC2 mutants were able to express car-
diomyocyte markers on day 8. In fact, most of the ZIC2 mutants failed
to express both NKX2-5 and TNNT2 (Figure 3C). These results
suggested two things: first, ZIC2 is essential for the formation of
MESP1+ cardiac mesodermal precursors that can commit to the car-
diomyocyte lineage; and second, ISL1 expression is not fully controlled
by the MESP1 signaling pathway and can be turned on irrespective of
F IGURE 3 ZIC2 mutant
reduce cardiac lineage
commitment. A, ZIC2 mutants fail
to express cardiac mesoderm
marker MESP1 on day 3. B, ZIC2
mutants are able to express
cardiac progenitor marker ISL1 on
day 6. C, Few of the ZIC2
mutated progenitors can
differentiate into cardiomyocyte
fate. Scale bar = 100 μm
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precedent expression of MESP1, although the myogenic ISL1+ progeni-
tors appear to be derived from the MEPS1+ lineage.
3.5 | ZIC2 is essential for the formation of cardiac
progenitors
To further explore the mechanism of ZIC2-mediated cardiac differen-
tiation, we analyzed bulk RNA sequencing (RNA-seq) data to compare
the transcriptome differences between wild type and the ZIC2-mutant
hESC-derived cells at different stages in cardiac differentiation: day
0, day 1, day 2, day 3, and day 6. These time points correspond to dis-
tinct development stages established in previous study,28 namely epi-
blast (day 0), primitive streak (day 1), early mesoderm (day 2), cardiac
mesoderm (day 3), and cardiac progenitor (day 6) stages, respectively.
Using multiple-dimensional scaling (MDS), we illustrated the relation-
ship of these samples. They were surprisingly close to each other at
the early stages. Both the mutant and the wild-type cells followed a
similar trajectory (Figure 4A). However, the number of differentially
expressed genes increased following the differentiation progress
(Figure 4B), with day 1, 25 up, 25 down; day 2, 27 up, 39 down; day
3, 53 up, 69 down; and day 6, 126 up, 167 down (wild type vs ZIC2
mutants). As shown in Figure 4C, by using classic cardiac differentia-
tion markers, we found the ZIC2 mutant cells were able to express
early mesoderm precursor markers, such as TBXT, EOMES, and MIXL1.
Conversely, the transcriptional similarities shown between the wild
type and mutant cells seceded from the cardiac progenitor stage
onward. Indeed, the ZIC2 mutants failed to commit to the car-
diomyocyte lineage, as indicated by the expression patterns of the
classical cardiomyocyte markers such as NKX2-5, MEF2C, TBX5,
MYH6, TNNT2, and MYL7, all of which were not induced in the ZIC2
mutants (Figure 4C).
The similar transcriptome profiles between the wild type and
ZIC2 mutant cells at the early stage suggest the ZIC2 mutants have
adopted the early mesodermal formation, while the differences at
later stage indicate the ZIC2 mutants fails to become cardiac progeni-
tors. These results suggest ZIC2 may play an essential role in the cell-
fate decision of the mesodermal precursor cells, which are considered
to be indispensable for the following induction of cardiac progenitors.
3.6 | ZIC2 mutants have switched the cell fate
of early mesodermal precursors into the osteoblast
lineage
To further decipher the molecular basis of causing the cell-fate switch
of the mesodermal precursor cells, we focused on the three major
developmental signaling pathways: TGFβ superfamily, wingless/Int-1
(WNT), and fibroblast growth factor (FGFs) (Figure 4D). The major dif-
ferences were highlighted in the FGF signaling pathways. The ZIC2
mutant cells showed higher expression of FGF8, FGF18, and FGF19 on
day 1 than wild-type cells. Both FGF8 and FGF18 were reported as
positive regulators for osteogenesis.33 On the contrary, FGF4 and
FGF13 had lower expression in the mutants. On day 6, FGF10, which
is regulated by ISL1, was highly expressed in the wild-type cells, but
not in the mutant cells. These observations suggest the incorrect FGF
paracrine cues may be one of the reasons for the derailed differentia-
tion program of the ZIC2 mutants.
Furthermore, among the differentially expressed genes on day
6, several osteogenesis-related genes such as RUNX2, DCN, and OGN
were upregulated in the ZIC2 mutants. In contrast, the cardiogenic
genes such as NKX2-5, MEF2C, PLN, and MYH6 were downregulated
in those cells (Figure 4E). By analyzing the protein-protein interaction
networks in the STRING database, the skeletal development network
was formed by the upregulated genes in the mutants on day 6 (Fig-
ure 4F). These results indicated the mutants might convert their cell
fate from cardiac to the osteoblast lineage.
Additionally, the ZIC2 mutants had more upregulated genes than
the downregulated genes when compared with the wild type
(Figure 4B), and among the upregulated genes, both cardiogenesis and
osteogenesis genes were found. MSX2, another pro-osteogenesis
gene,34 was upregulated in the mutants. Cardiogenesis genes, such as
ISL1, PITX2, were prematurely expressed in the mutant at cardiac
mesoderm stage, while these genes remained inactive or at a low
expression level in the wild types. On day 6, the cardiogenesis pro-
gram was successfully executed in the wild type, while it was shut
down in the ZIC2 mutants. Among the upregulated genes in the
mutants on day 6, an anticardiac factor CDX235 was found, suggesting
the ZIC2 mutants might not just adopt the osteogenic fate, but also
activate molecular programs that suppress the induction of the cardiac
cell fate. These results indicate one of the ZIC2 functions previously
unknown is to induce cardiac commitment and specification properly
during the in vitro human cardiogenesis.
3.7 | Single-cell RNA-seq analysis reveals
subpopulations emerging differently between the wild
type and ZIC2 mutant cells during mesoderm
formation
To further understand the role of ZIC2 that would play during the for-
mation of cardiac mesoderm, we analyzed single-cell RNA-seq data of
the wild type and ZIC2 mutant cells during cardiac mesoderm formation
on day 3, and sought to identify the subpopulations emerging differ-
ently from both cell types. On day 3 in cardiac differentiation, 384 cells
from each group, such as wild type and ZIC2 mutants (clones 1 and 2)
were harvested for single-cell RNA-seq analysis. Eventually, 362 cells
from the wild type, 339 cells from the ZIC2 clone 1, and 342 cells from
the ZIC2 clone 2 finally passed the quality control test and were then
used for the analysis. With a t-SNE approach, the analyzed cells were
segregated into three large groups, as shown in Figure 5A. There was a
group on the top, specifically composed by the wild-type cells. On the
contrary, there was a different group on the bottom, composed by
the two ZIC2 mutant clones. One another group, mainly composed by
the wild-type cells with a small fraction of the mutant cells, was also
found on the right side of the t-SNE panel (Figure 5A).
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We then examined expression patterns of the stage-specific
markers in cardiac differentiation on the analyzed cells in
Figure 5A. The pluripotency markers, POUR5F1, NANOG, and SOX2,
were highly expressed in both the top and bottom groups, while
expressed little or nothing (especially, NANOG and SOX2) in the right-
most group (Figure 5B). The lower expression of NANOG and SOX2 in
F IGURE 4 Profiling the differentiation of the ZIC2 mutants with RNA-Seq. A, MDS (multidimensional scaling) plot shows the transcription
profile similarity between the wild type and ZIC2 mutants. B, The number of differentially expressed genes (DEGs) comparing the wild type and
mutants at different stages. C, Heat map shows classic marker genes expressions. D, Heat map shows the dynamic expression of ligands from
WNT, TGFβ, and FGF signaling pathways. E, MD (mean-differential) plot show the DEGs on day 6 between the mutant and the wild type.
F, Protein-protein interaction network based on the DEGs on day 6 in the ZIC2 mutants suggests the mutants switch to osteoblast fate
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the rightmost group suggests this group is a more differentiated cell
population than the top and bottom groups. The primitive streak-
associated genes such as NODAL, MIXL1, and TBXT, which are nor-
mally highly expressed on day 1, were mainly expressed in the cells
located in the middle among the three groups, indicating a develop-
mental transition from the more immature top and bottom groups to
the rightmost group. On the other hand, the cardiac mesoderm
formation markers such as EOMES, MESP1, and TBX6, which are nor-
mally highly expressed on day 3, were mainly expressed in the right-
most group, suggesting that this group is most likely composed of the
cardiac mesoderm precursor cells, which the majority of the ZIC2
mutants failed to form (Figure 5B).
To proceed with a more detailed analysis, we adopted the k-
means method to further cluster the analyzed cells according to their
F IGURE 5 Single cell RNA-Seq reveal subpopulation difference between the wild type and ZIC2 mutants during mesoderm formation. A, tSNE
representation of the transcription profiles of the day 3 cells from wild type and ZIC2 mutants hESCs. B, tSNE plots with the expression distribution
of the classical developmental stage markers, including pluripotency markers: POU5F1, NANOG, SOX2; primitive markers: NODAL, MIXL1, T(TBXT);
mesoderm stage markers: EOMES, MESP1, TBX6. C, Subpopulation clusters based on the transcription profile. There are in total nine clusters, but
clusters 1-3 are very similar, so seven distinct populations can be identified. D, Heat map showing the marker genes of each cluster. Horizontal axis
shows the composition of the cells from different groups. The vertical axis on the left shows the color code for each cluster, and the vertical axis on
the right shows the names of marker genes. E, tSNE plots with the expression of example marker genes for different clusters
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gene expression patterns. After trying several parameters, we found
that processing the data set with a parameter “k = 9” yielded a reason-
able result (Figure 5C). In this setting, the initial top and rightmost
groups were subdivided into the two clusters, respectively. The top
group contained the clusters 4 and 9, while the rightmost group con-
tained the clusters 6 and 8. Since the bottom group involves the larg-
est number of cells, it was subdivided into 5 clusters, namely clusters
1 to 3, 5, and 7. Cells in the clusters 1 to 3 in the bottom group shared
very similar expression profiles, expressing the pluripotency markers
and being composed of only the mutants, which suggests that these
clusters were the ZIC2 mutated ES-like cells. The cells in the cluster
9 of the top group were also expressing pluripotency marker genes,
and thereby they were considered as wild-type ES-like cells. The clus-
ters 4 and 5 were apparently intermittent cell populations transiting
from the ES-like state to the mesoderm-like state. The primitive
streak-associated genes were expressed in the cells of the clusters
4 and 5. Cells in the clusters 6 and 8 in the rightmost group were con-
sidered as the mesoderm-like ones, because of expressing the early
and cardiac mesoderm formation marker genes. They formed a dis-
tinct population inside the rightmost group each other. Cells in the
cluster 7, located on the leftmost edge of the bottom group and com-
posed of only the ZIC2 mutated cells, were considered as more differ-
entiated cells that were completely different from the ES-like cells in
the clusters 1 to 3 and 9. These cells in the cluster 7 showed low
expression level of NANOG, but high-expression level of LHX5,
suggesting they were nonmesodermal cells but likely to be differenti-
ating into the neuronal lineage. A heat map image highlights the
marker genes for each of the cell clusters (Figure 5D), and expression
patterns of several newly identified marker genes are shown in
Figure 5E. Among all of the clusters, the cardiac mesoderm-like clus-
ters (clusters 6 and 8) are of most our interest. The markers for the
two clusters are the apelin receptor gene (APLNR) and LIX1
(Figure 5D,E). APLNR was not a very specific marker for the rightmost
group, since the cells in the top group also expressed this gene. How-
ever, cells in the cluster 6 showed the highest expression level of
APLNR (Figure 5E). Comparing the APLNR expression levels between
the clusters 6 and 8 within the rightmost group, the latter of which
contained more number of mutant cells than cluster 6, the cells in the
cluster 8 showed a weaker expression level of APLNR. This observa-
tion suggests that the APLNR-related signaling pathway that was
apparently activated in the wild-type cells during cardiac mesoderm
formation was attenuated in the ZIC2 mutants.
To further confirm the results analyzed earlier, we used alterna-
tive methods (ie, Seurat36,37 and U-map38) to analyze the data set. In
the end, similar results were obtained (Figure S4), and in them, APLNR
could still mark the cardiac mesoderm populations.
Taken together, the single-cell RNA-seq analysis newly identified
a distinct cardiac mesoderm forming population, which has the marker
genes, such as MESP1, TBX6, EOMES, and APLNR. This population
mainly contained the wild-type cells with only a small fraction of the
ZIC2 mutant-derived cells, suggesting that ZIC2 may play an important
role in the cell-fate decision of the early mesodermal precursors
through the APLNR-related signaling pathway, at least in part, during
the in vitro human cardiogenesis. To validate the obtained single cell
RNA-seq results, we examined in vitro protein expression of APLNR
during cardiac differentiation of the wild type and the ZIC2 mutated
hESCs. As shown in Figure S5, protein expression of a pluripotency
marker (POUR5F1 [Oct3/4]; day 0) and a primitive mesoderm precur-
sor marker (Brachyury; day 1-2) was comparable between the wild
type and the ZIC2 mutated hESC-derived cells, while protein expres-
sion of APLNR (day 1-3) was much attenuated in the ZIC2 mutants,
further supporting the single cell RNA-seq results.
3.8 | Differential roles of ZIC2 in human
and mouse cardiogenesis
Previous studies have shown that the Zic2 gene point mutation in
mouse models could recapitulate some of the developmental defects
in humans, such as holoprosencephaly.39-41 Cardiac defects, such as
random looping and ventricular septal defect, were also observed in
these mutant mice.39,42 However, if Zic2 would play an essential role
in murine cardiac progenitor formation, as seen in in vitro hESC differ-
entiation, it can be hypothesized that abnormal cardiac phenotypes in
mice with Zic2 gene mutation would become severer than was
thought before. Thus, as a proof-of-concept experiment to investigate
a potential role of Zic2 in murine cardiogenesis, we newly generated
Zic2-mutated murine embryos using CRISPR-Cas9 system through
zygote microinjection (see Methods). Two guide RNAs, approximately
500 bp apart from each other, were designed to target the exon 1 of
the murine Zic2 gene (Figure 6A). We have injected the guide RNAs
into 50 murine zygotes. Among them, 26 injected zygotes turned into
blastocysts, and only two developed into embryos on embryonic day
10.5 (E10.5). The results of PCR validation on the putative mutation
regions indicated a high degree of mosaic mutation in the generated
mutant mice (Figure 6B). Consistent with the previous reports,39-44
the E10.5 mutant embryos exhibited developmental defects in the
heads. The two cerebral hemispheres were clearly visible in the wild-
type embryo in the same stage, while these structures were atypical
in the mutant embryos (Figure 6C). There were no folds at the tops of
the wild type embryo, while the folds in the mutant embryos at the
same region were clearly visible (Figure 6C). We next focused on the
cardiac phenotypes in the mutant embryos. All the four chambers can
be identified in the Zic2 mutants (Figure 6D). From the left lateral
view, the morphology of the left ventricle and atrium were similar
between the wild type and mutant embryos. From the right lateral
view, the right ventricle and atrium also emerged in both embryos.
However, it appeared that the outflow tract region in the mutant
embryos were flatter as compared with that in the wild type embryo
(Figure 6D,E), suggesting that a slight outflow tract malformation
might be detectable at this stage in the mutant embryos.
Together, the earlier and our studies have demonstrated that Zic2
mutation in mice did not cause severe cardiac defect or malformation
leading to cardiac death during early embryogenesis. These observa-
tions are contrasted with the results of the in vitro hESC studies
described here, in which the ZIC2 mutant hESCs showed almost
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complete loss of the cardiomyocyte differentiation capabilities by
shifting the cell fate of early mesodermal precursor cells into the
noncardiac lineages. Collectively, our study identified the novel role of
ZIC2 as an essential regulator of early mesodermal precursors for car-
diac commitment and differentiation in in vitro human cardiogenesis,
and also highlights the potential species differences in regard to the
ZIC2-related cardiogenesis between mice and humans.
4 | DISCUSSION
CRISPR-knockout screen is a powerful forward genetic tool to dis-
cover genes responsible for the phenotype of interest. We report here
a hPSC-based CRISPR screen for discovering the essential genes for
cell-fate decision of early mesodermal precursors. hPSCs differentia-
tion systems have for long time been used for modeling and studying
the developmental process. The CRISPR-Cas9 genome editing pro-
vides a powerful tool for validating the function of a specific gene in
the hPSC models. The screening methods we reported here involved
the genome editing via the CRISPR-Cas9 technology and the develop-
ment modeling of in vitro hPSC differentiation. As demonstrated here,
hPSC mutant libraries are versatile, for they can be differentiated into
multiple lineages and used to discover indispensable genes for the
developmental commitment to specific cell lineages. For example, it
can also be used for discovering the regulators for the pluripotency
and proliferation of hPSCs, as shown in the current study. However,
F IGURE 6 Cardiogenesis occurs in
Zic2 mutated mice embryos. A, Targeted
sequences in Zic2 loci. Two guide RNAs
are labeled in red and their PAM site are
colored green. The functional two guide
RNAs will introduce a >500 bp
deletion. B, Electrophoresis of the PCR
product from the mutant and wild-type
embryo tissue. The expected size of the
wild type band is 682 bp and the
expected size of the mutant band is
153 bp. C, E10.5 embryos images of
mutant and wild-type mice. D, Zoom-in
view of the embryo heart. LA, left atrium;
LV, left ventricle; RA, right atrium; RV, left
ventricle. Scale bar = 500 μm
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this technology is still developing and has its limitations. First, the
mutation outcome and efficiency of the nonhomolog repair from the
CRISPR-Cas9 are still difficult to predict in spite of the large amount
of efforts that have been put into the library designing. Second, the
lack of strict selections usually causes high false positive rate. In the
setting of pool screenings, even cells with the same genetic mutation
might behave differently due to the local niche created by their neigh-
bors. To filter out these levels of variabilities, strict selection should
be applied in order to decrease the false positive rate. Otherwise, sec-
ond round of screening or laborious individual validation is necessary.
Third, the possibilities of potential off-target effects caused by recog-
nition of the similar sequence sites to the target sequence on the
human genome by guide RNAs cannot be completely excluded. About
the two guide RNAs used for generation of the ZIC2 mutated hESCs
(Figure 2B), putative off-target sites with the highest similarity (two to
three base pair mismatches in the PAM-distal part) to the target
sequence were identified and sequenced; however, there were no
mutations observed on those predicted off-target sites (Figure S6),
suggesting that off-target cleavage did not appear to occur for the
two guide RNAs.
In this study, we demonstrated the potential power of genome-
wide unbiased CRISPR-knockout screens to identify the key steps in
human mesodermal precursor cell- and heart progenitor cell-fate
determination during human cardiogenesis with in vitro hPSC model
systems. Through individual validations, we identified ZIC2 as an
essential gene that control the cardiac lineage commitment from early
mesodermal precursor cells.
The zinc finger of the cerebellum (ZIC) genes are well known to
have implication in neuroectoderm development and neural crest cell
induction.45 There are five ZIC genes in mammals, ZIC1 to ZIC5. They
all contain a five-Cys2His2-type zinc finger domain, which defines the
family. ZIC1 and ZIC4 are associated with Dandy-Walker malformation
(DWM).46 Mutations in ZIC2 cause a severe defect in forebrain devel-
opment known as holoprosencephaly (HPE).40 Mutations in ZIC3
cause X-linked heterotaxy in addition to neural tube defects.47,48 No
mutations have yet been described for ZIC5 in humans. Mouse models
have been used for the etiology study of these diseases. Zic3 null mice
exhibited approximately 50% embryonic lethality with additional 30%
lethality in the perinatal period.41 The mutant embryos had defects in
embryo turning, cardiac development, and neural tube closure.
Mice with one severe loss-of-function allele of Zic2 is known as
kumba. Unlike humans in which one allele mutation is sufficient to
cause to disease, mice with one kumba allele have no describable
defects, and the HPE phenotype presented only in the double mutant
case. Studies in mutant mice showed that HPE is produced by a tran-
sient defect in the development of prechordal plate, a structure
required for forebrain midline morphogenesis, validating the function
of Zic2 during organizer formation.44 The Zic2 null mice have cardiac
situs problems, indicating a L-R axis patterning defect.42 By examining
the embryos at later stages, more cardiovascular malformations have
been found, such as abnormal ventricular topology, great artery
transposition, double outlet right ventricle, ventricular septal defect,
and rightward looped aortic arch.39 Nevertheless, in our study, Zic2-
mutant murine embryos in the early stage (E10.5) had all four cham-
bers of the heart, further illustrating the different roles of ZIC2
required during cardiogenesis between mice and humans.
In terms of molecular functions, two functions of ZIC2 have been
previously reported: ZIC2 can bind directly to TCF4 and inhibit the
transcriptional activity of the β-catenin/TCF4 complex49; and ZIC2
can also function with Mbd3/NuRD in regulating the chromatin state
and transcriptional outputs of genes linked to differentiation.50 Based
on these previous studies, the mechanism we proposed here is the
inhibitory function of ZIC2, which allows the precise execution of spe-
cific molecular program for proper differentiation. During gastrulation,
immature cells are migrating through the primitive streak and form a
variety of mesodermal precursor cells. The activation signal is over-
whelming. Without strong and proper inhibitory systems, multiple dif-
ferentiation processes are likely activated at the same time and
compete to take control of the cells. The inhibitory system can
dampen spiking signaling and leaving the primary signals to convert
the cells into the appropriate progenitors and their progenies in a spa-
tiotemporal manner. By performing single-cell RNA-seq analysis of
the differentiating cells on day 3, we have captured the transitional
stage of early and cardiac mesoderm formation. By comparing the
wild type and the ZIC2 mutant cells, we found that unlike wild-type
cells, ZIC2 mutant cells could not enter the differentiation path into
the cardiac mesoderm lineage whereas they often differentiated into
other mesodermal lineages such as the osteoblast lineage, suggesting
that ZIC2 mutation switched the cell fate of the early mesoderm pre-
cursors. Further, although not frequently, some of the ZIC2 mutant
cells entered the differentiation path into the neuronal lineage while
none of the wild-type cells differentiated into the neuronal lineage,
suggesting that ZIC2 mutation might also affect the cell-fate upstream
the early mesodermal stage to some degree. Taken together, these
observations indicate that the ZIC2 mutant cells were somehow mis-
interpreting the environment signal and underwent un-directed differ-
entiation into the noncardiac lineages. In addition, we found that in
the mesoderm forming cluster (ie, cluster 6 in Figure 5C,E), which was
almost all composed of wild-type cells, the APLNR expression was
much higher than the rest of the clusters, for example, cluster 8 involv-
ing a lot of the ZIC2 mutant cells (Figure 5C,E), suggesting the
APLNR-related signaling pathway might be altered in the absence of
the functional ZIC2 gene. The APLNR signaling can modulate the
NODAL signaling pathway, a key pathway for mesendoderm induc-
tion.27,51 Although it remains unclear whether ZIC2 acts directly or
indirectly on the APLNR signaling pathway, our study connects ZIC2
with the APLNR signaling pathway in the early mesodermal precursor
cell-fate decision and cardiac lineage formation during cardiogenesis.
5 | CONCLUSION
We have developed a genome-wide CRISPR-knockout screen in
in vitro hPSC model systems to uncover crucial genes for the forma-
tion of human mesoderm precursors and heart progenitors, and iden-
tified ZIC2 as an essential gene for in vitro human cardiomyocyte
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commitment and differentiation. The transcriptome analysis and other
experimental evidence revealed the essential role of ZIC2 in human
cardiogenesis to control the cell fate of early mesodermal precursors
so as to directly differentiate into cardiac progenitors and thereafter
cardiomyocytes. These findings also provide new insights into the
potential congenital heart defects in patients with mutation of the
ZIC2 gene, emphasizing the importance of the cell-fate decision of the
mesodermal precursors in the early embryonic stage for proper car-
diogenesis in humans.
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